Efficacy of Intranasal Esketamine in Treatment‐Resistant Depression: A Six‐Month Real‐World Follow‐Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk
Our findings indicate an overall response regarding depressive symptoms, hopelessness, and suicidal ideation after esketamine in treatment-resistant depression at 3-month and 6-month follow-up assessments.
Authors
- Isabella Berardelli (ORCID: https://orcid.org/0000-0003-0602-871X)
- Denise Erbuto (ORCID: https://orcid.org/0000-0002-6403-7254)
- Salvatore Sarubbi (ORCID: https://orcid.org/0000-0002-8105-0370)
- Maria Anna Trocchia
- Ludovica Longhini
- Maurizio Pompili (ORCID: https://orcid.org/0000-0003-1886-4977)
- Cristina Di Legge
- Eva Dispenza
Institutions
- Azienda Ospedaliera Sant'Andrea (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Human Psychopharmacology Clinical and Experimental
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1002/hup.70008
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79